Nurse Practitioner · Las Vegas, NV
NPI
1407263106
Since 2014
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
7730 W Cheyenne Ave Ste 107
Las Vegas, NV, 89129
Phone (725) 221-1568
Groups this clinician bills Medicare through
Medicare paid, 2024
$161K
8,256 services
Medicare patients, 2024
483
Average age 72
Drug cost, 2024
$4.0M
3,817 prescriptions
Company payments, 2025
$5,848
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Teodoro Agtay was code J0585 (injection, onabotulinumtoxina, 1 unit), 6,085 times for 11 patients. In total Teodoro Agtay billed 8,256 services in 17 codes, and Medicare paid $161K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 6,085 | 11 | $4.92 | $30K |
| 99232 Hospital E&M - Subsequent | Facility | 976 | 221 | $51.14 | $50K |
| 99308 SNF E&M | Facility | 606 | 97 | $48.22 | $29K |
| 99223 Hospital E&M - Initial | Facility | 167 | 158 | $112.11 | $19K |
| 99213 Office E&M - Established | Office | 149 | 97 | $55.26 | $8,234 |
| 99214 Office E&M - Established | Office | 78 | 59 | $77.23 | $6,024 |
| 99306 SNF E&M | Facility | 60 | 60 | $117.12 | $7,027 |
| 99204 Office E&M - New | Office | 37 | 37 | $102.42 | $3,790 |
| 64615 Musculoskeletal | Office | 37 | 13 | $100.47 | $3,718 |
| 99233 Hospital E&M - Subsequent | Facility | 21 | 17 | $76.98 | $1,617 |
By year: 2022 $78K for 3,080 services; 2023 $122K for 7,418 services; 2024 $161K for 8,256 services.
Medicare prescription drug claims, 2024
In 2024, the drug Teodoro Agtay prescribed most often to Medicare patients was Gabapentin, with 397 prescriptions and refills. In total Teodoro Agtay wrote 3,817 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 397 | 716 | 116 | $4,772 |
| Donepezil Hcl Generic | 319 | 793 | 115 | $2,515 |
| Pregabalin Generic | 223 | 401 | 67 | $4,885 |
| Memantine Hcl Generic | 221 | 458 | 66 | $7,001 |
| Duloxetine Hcl Generic | 132 | 276 | 40 | $3,202 |
| Topiramate Generic | 128 | 240 | 40 | $613 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 123 | 256 | 33 | $2,747 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 108 | 120 | 38 | $2,985 |
| Primidone Generic | 94 | 218 | 26 | $1,088 |
| Baclofen Generic | 86 | 130 | 24 | $1,463 |
| Celecoxib Generic | 83 | 96 | 21 | $753 |
| Levetiracetam Generic | 73 | 171 | 22 | $2,127 |
| Kesimpta Pen Ofatumumab | 71 | 79 | Under 11 | $735K |
| Botox Onabotulinumtoxina | 65 | 175 | 23 | $81K |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 61 | 61 | Under 11 | $847K |
Brand drugs: - claims; generic drugs: 3,122 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Teodoro Agtay $5,848 ($5,848 in general payments such as food, travel and fees) from 35 companies. The largest payer was Abbvie Inc. with $1,168.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 67 | $1,168 |
| Argenx US, Inc. ARGX | 21 | $551 |
| UCB, Inc. UCB.BR | 17 | $403 |
| TG Therapeutics, Inc. TGTX | 8 | $390 |
| Novartis Pharmaceuticals Corporation NVS | 34 | $350 |
| Teva Pharmaceuticals USA, Inc. TEVA | 10 | $327 |
| EMD Serono, Inc. MRK.DE | 11 | $290 |
| Genentech USA, Inc. ROG.SW | 10 | $224 |
| Pfizer Inc. PFE | 13 | $215 |
| Neurocrine BioSciences, Inc. NBIX | 6 | $191 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.